Illumina
ILMN
267.76
-5.78
-2.11%
Illumina
US · ILMN
#539 by market cap
Listed 1970
267.76
-5.78
-2.11%
Live - 5344 symbols - heartbeat 106s ago
· 2026-10-08 06:30
Pre-market
265.02
-1.02%
After-hours
267.81
+0.02%
Overnight
266.31
-0.54%
- Market cap
- 40.43B
- P/E (TTM)i
- 49.96
- P/Bi
- 14.25
- EPSi
- 5.45
- Div yieldi
- 0.00%
- 52W posi
- 81%
Reader sentiment
Are you bullish or bearish on ILMN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.47, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.66% YoY
Margins
- Gross margin
- 66.08%
- Operating margin
- 18.81%
- Net margin
- 19.57%
Key ratios & quality
- Enterprise valuei
- 40.87B
- Altman Z-Scorei
- 7.47
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.33B | 3.54B | 3.24B | 4.53B | 4.58B | 4.50B | 4.37B | 4.34B |
| Gross profit | 2.30B | 2.47B | 2.20B | 3.15B | 2.97B | 2.74B | 2.86B | 2.87B |
| Selling & admin expenses | 794.00M | 835.00M | 941.00M | 2.09B | 1.30B | 1.61B | 1.09B | 1.09B |
| Research & development | 623.00M | 647.00M | 682.00M | 1.19B | 1.32B | 1.35B | 1.17B | 967.00M |
| Operating profit | 883.00M | 985.00M | 580.00M | -123.00M | 354.00M | -222.00M | 600.00M | 817.00M |
| Pretax profit | 894.00M | 1.12B | 856.00M | 884.00M | -4.34B | -1.12B | -1.18B | 1.09B |
| Tax | 112.00M | 128.00M | 200.00M | 122.00M | 68.00M | 44.00M | 44.00M | 236.00M |
| Net profit | 782.00M | 990.00M | 656.00M | 762.00M | -4.40B | -1.16B | -1.22B | 850.00M |
| Basic EPS | 6 | 7 | 4 | 5 | -28 | -7 | -8 | 5 |
| Diluted EPS | 5.56 | 6.74 | 4.45 | 5.04 | -28.00 | -7.34 | -7.69 | 5.45 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.04B | 1.06B | 1.08B | 1.16B | 1.09B | 1.16B |
| Gross profit | 683.00M | 695.00M | 733.00M | 759.00M | 721.00M | 770.00M |
| Selling & admin expenses | 267.00M | 234.00M | 277.00M | 309.00M | 272.00M | 273.00M |
| Research & development | 252.00M | 247.00M | 229.00M | 239.00M | 240.00M | 252.00M |
| Operating profit | 164.00M | 214.00M | 227.00M | 211.00M | 209.00M | 245.00M |
| Pretax profit | 182.00M | 306.00M | 220.00M | 377.00M | 157.00M | 260.00M |
| Tax | 51.00M | 71.00M | 70.00M | 43.00M | 23.00M | 53.00M |
| Net profit | 131.00M | 235.00M | 150.00M | 334.00M | 134.00M | 207.00M |
| Basic EPS | 1 | 1 | 1 | 2 | 1 | 1 |
| Diluted EPS | 0.82 | 1.49 | 0.98 | 2.16 | 0.87 | 1.35 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.49B | 4.45B | 4.48B | 2.71B | 3.56B | 2.61B | 2.75B | 3.29B |
| Cash & ST investments | 3.51B | 3.41B | 3.47B | 1.34B | 2.04B | 1.05B | 1.22B | 1.63B |
| Inventory | 386.00M | 359.00M | 372.00M | 431.00M | 568.00M | 587.00M | 547.00M | 564.00M |
| Total assets | 6.96B | 7.32B | 7.59B | 15.22B | 12.25B | 10.11B | 6.30B | 6.64B |
| Total current liabilities | 1.80B | 665.00M | 1.24B | 1.09B | 2.77B | 1.57B | 1.55B | 1.59B |
| Short-term debt | 1.11B | 45.00M | 562.00M | 71.00M | 1.32B | 86.00M | 578.00M | 577.00M |
| Long-term debt | 890.00M | 1.14B | 673.00M | 1.70B | 1.49B | 1.49B | 1.49B | 1.49B |
| Total liabilities | 3,114,000,000.00 | 2,703,000,000.00 | 2,891,000,000.00 | 4,477,000,000.00 | 5,653,000,000.00 | 4,366,000,000.00 | 3,930,000,000.00 | 3,921,000,000.00 |
| Total equity | 3.85B | 4.61B | 4.69B | 10.74B | 6.60B | 5.75B | 2.37B | 2.72B |
| Retained earnings | 3.08B | 4.07B | 4.72B | 5.49B | 1.14B | -19.00M | -1.24B | -392.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.67B | 2.64B | 2.80B | 3.29B | 2.74B | 2.83B |
| Cash & ST investments | 1.24B | 1.16B | 1.28B | 1.63B | 1.16B | 1.17B |
| Inventory | 537.00M | 575.00M | 590.00M | 564.00M | 611.00M | 629.00M |
| Total assets | 6.18B | 6.09B | 6.18B | 6.64B | 6.56B | 6.65B |
| Total current liabilities | 1.44B | 1.46B | 1.96B | 1.59B | 1.57B | 1.58B |
| Short-term debt | 577.00M | 578.00M | 1.08B | 577.00M | 579.00M | 582.00M |
| Long-term debt | 1.49B | 1.49B | 994.00M | 1.49B | 1.49B | 1.49B |
| Total liabilities | 3,814,000,000.00 | 3,829,000,000.00 | 3,796,000,000.00 | 3,921,000,000.00 | 3,883,000,000.00 | 3,812,000,000.00 |
| Total equity | 2.37B | 2.26B | 2.38B | 2.72B | 2.68B | 2.84B |
| Retained earnings | -1.11B | -876.00M | -726.00M | -392.00M | -258.00M | -51.00M |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.14B | 1.05B | 1.08B | 545.00M | 392.00M | 478.00M | 837.00M | 1.08B |
| Depreciation & amortization | 179.00M | 188.00M | 187.00M | 251.00M | 394.00M | 432.00M | 354.00M | 270.00M |
| Free cash flow | 846.00M | 842.00M | 891.00M | 337.00M | 106.00M | 283.00M | 709.00M | 931.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -155.00M | -265.00M | -675.00M | 60.00M | 63.00M | 67.00M | -60.00M | -698.00M |
| Ending cash balance | 1.14B | 2.04B | 1.81B | 1.23B | 2.01B | 1.05B | 1.13B | 1.42B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 240.00M | 234.00M | 284.00M | 321.00M | 289.00M | 201.00M |
| Depreciation & amortization | 69.00M | 68.00M | 67.00M | 66.00M | 69.00M | 70.00M |
| Free cash flow | 208.00M | 204.00M | 253.00M | 266.00M | 251.00M | 161.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -173.00M | -369.00M | -114.00M | -42.00M | -218.00M | -128.00M |
| Ending cash balance | 1.11B | 934.00M | 1.05B | 1.42B | 1.09B | 1.04B |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 25.39 | 23.94 | 14.10 | 9.87 | -50.80 | -18.81 | -30.13 | 33.36 |
| ROA %i | 13.52 | 14.04 | 8.80 | 6.68 | -32.07 | -10.38 | -14.90 | 13.13 |
| ROIC %i | 17.02 | 16.03 | 10.11 | 8.20 | -37.49 | -12.62 | -18.16 | 17.48 |
| 5-year avg ROE %i | 25.73 | 25.80 | 23.04 | 20.52 | 4.50 | -4.34 | -15.15 | -11.30 |
| EBIT margin %i | 28.53 | 33.02 | 27.94 | 20.88 | -94.02 | -23.09 | -24.68 | 27.33 |
| FCF / sales %i | 25.38 | 23.77 | 27.51 | 7.45 | -- | 6.26 | 16.22 | 21.44 |
| Current ratioi | 2.49 | 6.69 | 3.60 | 2.48 | 1.28 | 1.66 | 1.78 | 2.08 |
| Quick ratioi | 2.23 | 6.00 | 3.18 | 1.82 | 0.98 | 1.14 | 1.26 | 1.57 |
| Debt / assetsi | 28.70 | 25.71 | 25.13 | 16.69 | 29.02 | 22.37 | 41.60 | 38.43 |
| LT debt / equityi | 23.68 | 39.80 | 28.63 | 22.99 | 33.81 | 37.88 | 86.14 | 72.57 |
| Interest coveragei | 16.68 | 22.50 | 18.47 | 15.49 | -165.77 | -13.51 | -10.79 | 11.75 |
| Revenue CAGR (3Y) %i | 14.51 | 13.90 | 5.58 | 10.74 | 8.97 | 11.62 | -1.15 | -1.78 |
| Net income CAGR (3Y) %i | 21.37 | 29.35 | -3.32 | -2.65 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 9.58 | 18.34 | 16.54 | -26.42 | -49.88 | -31.77 | 28.14 | 106.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -23.85 | 68.06 | 31.20 | 33.36 | 33.82 | 32.34 |
| ROA %i | -11.91 | 20.66 | 11.53 | 13.13 | 13.39 | 12.94 |
| ROIC %i | -14.12 | 28.64 | 15.38 | 17.48 | 17.68 | 17.08 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -18.01 | 35.15 | 23.23 | 27.33 | 26.43 | 24.77 |
| FCF / sales %i | 20.04 | 23.90 | 23.32 | 21.44 | 22.17 | 20.72 |
| Current ratioi | 1.86 | 1.81 | 1.43 | 2.08 | 1.75 | 1.80 |
| Quick ratioi | 1.34 | 1.27 | 1.02 | 1.57 | 1.21 | 1.22 |
| Debt / assetsi | 42.17 | 42.68 | 41.70 | 38.43 | 38.79 | 38.00 |
| LT debt / equityi | 85.73 | 89.46 | 63.00 | 72.57 | 73.43 | 68.53 |
| Interest coveragei | -7.30 | 13.57 | 9.96 | 11.75 | 11.61 | 11.36 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Consumables is the largest reported line at 73.51% of revenue, across 3 reported segments.
- The next-largest line, Service and other revenue, is a distant second at 15.27% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Consumables73.51%
Service and other revenue15.27%
Instruments11.22%
Quote time 2026-10-08 06:30:28 · For reference only, not investment advice and not tailored to your situation.